For many individuals navigating a cancer diagnosis, the clinical journey does not conclude with the final round of chemotherapy or the last session of radiation therapy. While the biological battle against a tumor is often the primary focus of medical intervention, the broader human experience—characterized by chronic pain, psychological trauma, financial devastation, and the complex challenge of post-treatment reintegration—often remains inadequately addressed. Recognizing this critical gap, the Uganda Cancer Institute (UCI) has inaugurated a transformative institutional framework: the Division of Oncology Palliative Care and Cancer Survivorship. This strategic development marks a pivot from a strictly curative model toward a comprehensive, patient-centered approach that addresses the multi-faceted burden of the disease.
A Growing Global Crisis
The establishment of this division occurs against the backdrop of a relentless global escalation in cancer prevalence. According to the World Health Organization’s (WHO) most recent data, 2024 saw approximately 20.6 million new cancer diagnoses worldwide, contributing to a mortality toll of nearly 9.8 million lives. These statistics, while staggering in their magnitude, often obscure the profound social and economic realities faced by patients and their support networks.
In Uganda, the challenge is particularly acute. With an estimated 36,000 new cases diagnosed annually, the UCI operates under immense pressure. Compounding this demand is the late-stage presentation of the disease; more than 75% of patients in the country report to medical facilities only after their cancer has progressed to an advanced, often incurable state. In this context, the mandate of the new division is not merely a supplementary service but a fundamental pillar of public health strategy.
The Evolution of Palliative Care at UCI
Historically, palliative care has been misunderstood as a service exclusively reserved for the final days of life. The UCI’s new division is designed to dismantle this misconception. By integrating palliative care into the primary oncology pathway, the Institute aims to provide relief from physical, psychosocial, and spiritual distress from the moment of diagnosis.
The WHO defines palliative care as an essential approach to improving the quality of life for patients and families facing life-threatening illnesses. It is a proactive methodology that seeks to prevent and alleviate suffering, regardless of the stage of the disease. Despite its proven efficacy—relieving symptoms for over 90% of advanced cancer patients—the global reach of these services remains strikingly low. The WHO estimates that of the 56.8 million people requiring palliative care annually, only 14% currently have access to it.
By formalizing this division, the UCI is positioning itself as a leader in bridging this gap. The division integrates a specialized team of experienced palliative care nurses and oncologists, moving beyond the ad-hoc support systems of the past toward a structured, institutionalized department. This allows for the seamless transition of care, whether a patient is receiving curative treatment, managing a chronic condition, or transitioning to end-of-life care.
The Survivorship Mandate
While palliative care addresses the complexities of advanced disease, the "survivorship" component of the new division recognizes the changing demographics of the oncology ward. Advances in diagnostic tools and treatment protocols have increased survival rates for various cancers, leading to a growing population of individuals living "beyond" their diagnosis.
Survivorship is not a static state. For many, it entails a prolonged period of medical monitoring, physical rehabilitation, and psychological adjustment. Survivors frequently face "late effects"—long-term consequences of treatment that can impact organ function, fertility, and mental health. The new division at the UCI is tasked with establishing protocols to monitor these survivors, ensuring that the transition from patient to survivor is supported by clinical vigilance and emotional resources. This initiative acknowledges that the oncology journey does not simply "stop" when the disease is in remission; for many, it evolves into a permanent state of managed wellness.

Economic Implications and Financial Toxicity
A critical, often overlooked aspect of the UCI’s new strategy is the recognition of "financial toxicity." Cancer is a major driver of household poverty, particularly in resource-limited settings like Uganda. The financial burden extends beyond the direct costs of medication and hospital stays. It encompasses the loss of income for the patient, the loss of productivity for the family members acting as caregivers, and the long-term debt incurred during the treatment process.
By addressing the social and financial dimensions of the cancer journey, the Division of Oncology Palliative Care and Cancer Survivorship aims to mitigate the secondary trauma caused by economic instability. This represents a holistic understanding of health, acknowledging that medical outcomes are inextricably linked to the socio-economic wellbeing of the patient’s household.
Chronology of Institutional Development
The creation of this division is the culmination of years of advocacy and internal scaling at the UCI. While the Institute has historically managed a palliative care team, the formalization of the division serves as a milestone in the following trajectory:
- Early Phase: Initial integration of palliative care services as an auxiliary nursing function.
- Expansion Phase: Recruitment of specialized doctors and nurses to address the rising volume of patients, which currently averages 10,000 new intakes annually.
- Formalization: The strategic establishment of the Division of Oncology Palliative Care and Cancer Survivorship to integrate these services into the broader oncology pathway.
- Operational Integration: The current phase, focusing on standardizing protocols, developing long-term survivorship clinics, and establishing bereavement support systems for families.
Broader Impact and Future Implications
The implications of the UCI’s new division extend far beyond the walls of the institute. By elevating palliative care and survivorship to a divisional status, the UCI is setting a standard for oncology centers across East Africa. It signals a shift in the philosophy of care—one that prioritizes dignity, comfort, and the restoration of quality of life alongside the medical objective of tumor reduction.
Medical experts suggest that this model could significantly improve treatment adherence. Patients who feel supported in their psychological and social needs are more likely to complete their treatment regimens, thereby improving overall clinical outcomes. Furthermore, the focus on family support addresses the systemic burden of cancer, ensuring that the caregivers—who are the backbone of the patient’s support network—are also provided with the resources they need to navigate the crisis.
In a health system constantly grappling with the constraints of limited resources and a surging disease burden, the UCI’s decision is both pragmatic and ethical. It recognizes that in the face of a complex, life-altering disease, the medical system must offer more than just chemotherapy; it must offer a comprehensive framework of support that carries the patient through the darkest points of their diagnosis and into the light of survivorship.
As the Uganda Cancer Institute continues to refine this model, the focus will remain on sustainability and accessibility. The challenge moving forward will be ensuring that these services reach the most vulnerable, particularly those in rural areas who face the greatest barriers to consistent care. However, the establishment of the division represents a significant and necessary step toward a more compassionate and effective oncology infrastructure in Uganda.
Ultimately, the goal is to redefine what it means to "fight" cancer. It is no longer just about the battle to eliminate a tumor, but the enduring commitment to uphold the quality of life, provide emotional sanctuary, and ensure that no patient is left to face the physical, financial, and psychological consequences of their illness in isolation. For the thousands of Ugandans currently walking this path, the new division provides a critical promise: that their care will continue, evolve, and sustain them, long after the initial diagnosis is given.


